TACE Study-Liver Embolization Perfusion (VGH Radiology LIU)

NCT02093104 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2017-05-08

No results posted yet for this study

Summary

The purpose of this research study is to evaluate the quantitative information of utilizing C-arm systems in liver tumor care in hopes this potential clinical combination of imaging could aid in diagnosis and evaluation of tumor therapy.

Conditions

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • David MT Liu, MD · UBC/VCHA/VGH

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02093104 on ClinicalTrials.gov